Stocks to Watch: Starbucks, TI, UPS (Update 1)

Starbucks ( SBUX _ ) plans to sell a single-cup coffee machine that will go on sale this fall online, at high-end specialty stores and at some Starbucks cafes.

Starbucks' Verismo is a blow to Green Mountain Coffee Roasters ( GMCR _ ) , the maker of the Keurig single-serve machines. Starbucks started selling K-cup packs for the Keurig machines last November.

"This is not about any disappointment with Green Mountain; it's about controlling our own destiny." Starbucks CEO Howard Schultz said. "They can and they will co-exist."

Shares of Starbucks were up 3% to $51.86 before the bell.

Green Mountain shares fell 14.3% to $53.50.

Texas Instruments ( TXN _ ) slashed its first-quarter guidance, saying it still sees a reduction in demand for its wireless products.

The Dallas-based chipmaker lowered its first-quarter earnings outlook to 15 cents to 19 cents a share on revenue of between $2.99 billion to $3.11 billion. It had previously expected earnings of 16 cents to 24 cents a share on revenue of $3.02 billion to $3.28 billion.

Analysts polled by Thomson Reuters forecast Texas Instruments to report first-quarter earnings of 31 cents a share on revenue of $3.16 billion.

Shares of Texas Instruments were down 1.1% to $32.25.

United Parcel Service ( UPS _ ) is close to an agreement to buy TNT Express ( TNT   ) , Europe's second largest package delivery company, according to several news sources.

UPS's initial $6.5 billion offer was rejected until it upped its bid to €9 a share last month. According to Bloomberg , which cited an anonymous source, an announcement may come next week.

The deal would give UPS a leg against its competitor FedEx . UPS currently has a 7.7% share of the European market while FedEx has 3.3%. TNT and Deutsche Post have the most market share, with 9.6% and 17.6%, respectively.

Boston Scientific ( BSX _ ) will buy privately held Cameron Health in a deal worth $150 million. Boston Scientific will potentially pay an additional $150 million after the U.S. Food & Drug Administration approves Cameron's S-ICD wireless system, a subcutaneous implantable defibrillator.

As part of the deal, the buyer will pay $1.05 billion in revenue-based milestone payments over a six-year period.

Shares of Boston Scientific were up 0.3% to $5.95 before the bell.